Name: Global AI in Drug Manufacturing Market Size and Trends 2040
Creator: Roots Analysis
Published: 2025-09-02T00:00:01+05:30
License: https://www.rootsanalysis.com/privacy.html
Keywords: AI in Drug Manufacturing Market, AI in Drug Manufacturing Market Growth, AI in Drug Manufacturing Market Trends, AI in Drug Manufacturing Market Size, AI in Drug Manufacturing Market Share, AI in Drug Manufacturing Market Analysis, AI in Drug Manufacturing Market Forecast, AI in Drug Manufacturing Market Report, Global AI in Drug Manufacturing Market, AI in Drug Manufacturing Industry

Global AI in Drug Manufacturing Market Size

The global AI in drug manufacturing market is estimated to grow from USD 0.9 billion in 2025 to reach USD 1.2 billion in 2026 and USD 34.8 billion by 2040, representing a CAGR of 27.2% during the forecast period 2026 to 2040.

AI in Drug Manufacturing Market Landscape

See What’s in the Full Report - Request Your Complimentary Insights!

Artificial Intelligence (AI) is a branch of computer science that allows computers to carry out complex tasks that traditionally require human intelligence, such as learning, reasoning and decision making. AI in healthcare is already being utilized across various use cases, including drug discovery, clinical trials, diagnostics, personalized medicine and data management. In pharmaceutical manufacturing, AI leverages technologies like computer vision, machine learning, generative AI, deep learning to enhance process monitoring, identify bottlenecks, reduce production costs, and increase product yield.

Click On The Thumbnails To View The Full Image

AI in Drug Manufacturing Market Distribution by Type of Offering

AI in Drug Manufacturing Market Partnerships and Collaborations

Pharmaceutical manufacturing is associated with various inefficiencies, such as suboptimal workflows, equipment downtime, quality control issues, and supply chain disruptions. These inefficiencies can lead to increased costs, production delays, and inconsistencies in product quality. AI can address these challenges by facilitating process optimization, monitoring plant / equipment performance, predicting equipment failures before they occur, supply chain management, and automating quality control.

Several pharmaceutical companies, such as Pfizer, Moderna, Novartis, Merck and Sanofi, are implementing AI into their manufacturing processes as the industry shifts towards Pharma 4.0. For instance, Pfizer deployed AI to detect anomalies and recommend real-time actions to operators, with the aim of reducing cycle time by 25% and improving product yield by 10%.

Click On The Thumbnails To View The Full Image

AI in Drug Manufacturing Market Funding and Investment Analysis

AI in Drug Manufacturing Market Start-up Health Indexing

AI in Drug Manufacturing Market Megatrends Analysis

Recently, the US government launched the Equip-A-Pharma program, a collaborative initiative led by the U.S Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), and the Defense Advanced Research Projects Agency (DARPA). The program involves various private sector partners, such as Battelle Memorial Institute, Aprecia, BrightPath Laboratories, and Mark Cuban Cost Plus Drug Company. Notably, this program aims to revolutionize the pharmaceutical manufacturing in the US using artificial intelligence, machine learning, and informatics.

AI in Drug Manufacturing Market: Report Attributes

Key Report Attributes	Details
Historical Trend	Since 2021
Forecast Period	Till 2040
Market Size 2026	$ 1.2 Billion
Market Size 2040	$ 34.8 Billion
CAGR (Till 2040)	27.2%

The AI in drug manufacturing market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of offering, mode of deployment, type of AI solution, type of technology, application area, utility in drug manufacturing, geographical regions and key players.

We have created three market forecast scenarios, conservative, base and optimistic, to account for future uncertainties in key parameters and enhance the robustness of our model. These scenarios represent different tracks of the industry's evolution.

Click On The Thumbnails To View The Full Image

AI in Drug Manufacturing Market Impact Analysis

AI in Drug Manufacturing Market By Geographical Regions

AI in Drug Manufacturing Market Key Segment Opportunities

The adoption of AI in drug manufacturing is expected to rise substantially as regulatory agencies increasingly acknowledge its value in enhancing quality, efficiency, and compliance. For instance, during the 2024 ISPE conference, Sharmista Chatterjee (Division Director at FDA / CDER) stated “AI is going to play a significant role in pharmaceutical manufacturing in the next five to ten years.” She further emphasized that AI is a priority within the agency’s FRAME (Framework for Regulatory Advanced Manufacturing Evaluation) initiative.

Recent Developments in AI in Drug Manufacturing Market

Several recent developments have taken place in the field of artificial intelligence in drug manufacturing, and we outline some of these below. These developments, even if they arose after our market report’s release, support the overall AI in drug manufacturing market trends detailed in our analysis.

In June 2025, Aizon entered into a partnership with Sequence aimed at delivering comprehensive, AI-powered solutions for the pharmaceutical industry.

In April 2025, SCW.AI entered into a partnership with Sequence to accelerate digital transformation in pharmaceutical manufacturing.

In June 2025, Antares, in collaboration with Oròbix, launched the AI-Go platform, which provides advanced visual inspection and quality control capabilities for the pharmaceutical and manufacturing packaging sectors.

In March 2025, Infinite Uptime raised $35 million in its series C funding round to expand its presence in the US and other international markets.

Get an Instant Quote in 10 Minutes. Lowest Price Guaranteed

AI in Drug Manufacturing Market Segmentation Insights

The market report presents an in-depth analysis of various AI solution providers for drug manufacturing companies, across different segments, as defined in the table below:

AI in Drug Manufacturing Market: Market Segmentation

Market Segmentations	Details
Type of Offering	Hardware Software Services
Mode of Deployment	Cloud On-premise
Type of AI solution	Standard / Off-the-shelf AI solutions Personalized AI solutions
Type of Technology	Computer Vision Deep Learning Generative AI Machine Learning Other Technologies
Application Area	Process Development and Optimization Plant / Equipment Performance Monitoring Predictive Maintenance Quality Control Supply Chain Optimization Other Application Areas
Utility in Drug Manufacturing	Defect Detection Packaging and Label Inspection Package Counting Fill Level Inspection Other Utilities
Geographical Regions	North America Europe Asia-Pacific Middle East and North Africa Latin America
Market in North America	US Canada
Market in Europe	Germany UK Italy Spain France Rest of Europe
Market in Asia-Pacific	China India Japan Korea Australia
Market in Middle East and North Africa	Saudi Arabia UAE Egypt Rest of MENA
Market in Latin America	Brazil Argentina Rest of Latin America

Industry Experts on Artificial Intelligence in Drug Manufacturing

Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes detailed transcripts of interviews conducted with the following individuals:

Founder, Mid-Sized Company in the US
Vice President of New Business Development, Small Company in the US
Senior Product Marketing Manager, Mid-Sized Company in the US
Marketing Director, Mid-Sized Company in Israel
Founder, Small Company in Hungary

In addition, the market report includes transcripts of the following other third-party discussions:

Director, Data Science, Large Company in the US
Business Lead Digital Core Transformation, Large Company in Switzerland
Chief Revenue Officer, Mid-Sized Company in the US
Chief Commercial Officer, Mid-Sized Company in Denmark
Founder, Mid-Sized Company in Turkey
Founder, Mid-Sized Company in the US
Strategic Advisor, Mid-Sized Company in the US
Global Head of Data Science, Large Company in France
Technical Client Manager, Large Company in the US
Senior Manager, Sales and Business Consulting, Large Company in Germany
Director - Robotics & Operational Technology, Large Company in Denmark
Chief Executive Officer, Mid-Sized Company in the US
Vice President Information Technology, Large Company in the US
Chief Scientific and Compliance Officer, Mid-Sized Company in the US

AI in drug manufacturing industry will mark a turning point in 2025. Geri Studebaker (Chief Commercial Officer, Aizon), states, “2025 is poised to be the tipping point when AI moves from being a competitive edge for early adopters to an industry-wide must-have, reshaping pharmaceutical production as we know it.”

Market Share by Type of Offering: Software Segment to Dominate the Overall Market

The global AI in drug manufacturing market is divided into various sub-segments based on the type of offering, namely hardware, software, and services. In 2026, the software segment (45%) is expected to dominate the market, and is likely to grow at a higher CAGR (28.4%) during the forecast period.
This dominance is driven by the increasing adoption of software-based solutions that integrate advanced techniques, such as predictive analytics, anomaly detection, generative AI models, and process optimization, thereby improving operational efficiency and foster innovation in drug manufacturing.

Market Share by Mode of Deployment: Cloud-based Solutions Hold the Largest Share

Based on the mode of deployment, the overall market includes cloud-based deployment and on-premise deployment. In the current year, cloud-based deployment (62%) holds the higher market share and is likely to grow at a higher CAGR (28.1%) during the forecast period.
This dominance is a result of its flexibility, ease of deployment, and lower upfront infrastructure costs when compared to on-premise solutions. Further, as regulatory frameworks increasingly support compliance for cloud-based solutions, the industry is gradually shifting from on-premises infrastructure to hybrid models.

Market Share by Type of AI Solution: Off-the-shelf AI Solutions to Dominate the Overall Market

Based on the type of AI solution, the global market includes standard / off-the-shelf AI solutions and personalized AI solutions. Currently, standard / off-the-shelf AI solutions (57%) hold the higher market share and are likely to grow at a higher CAGR (30.0%) during the forecast period.
This is primarily due to industry’s preference towards pre-validated, compliant, and ready-to-deploy solutions that can be deployed and scaled rapidly.

Market Share by Type of Technology: Computer Vision Holds the Largest Share

There are different sub-segments of global market based on the type of technology, such as computer vision, deep learning, generative AI, machine learning and other technologies. In 2026, computer vision (36%) holds a higher market share due to its early and widespread adoption in automated quality control applications, which allowed it to gain significant traction across pharmaceutical industry.
It is worth highlighting that the market share for generative AI is likely to grow at a relatively higher CAGR (29.9%), during the forecast period, driven by advanced capabilities of generative AI in healthcare domain, such as in predictive analytics, process optimization and real time insights.

Market Share by Application Area: Supply Chain Optimization to propel the market in the Coming Years

This segment highlights the distribution of market across diverse types of applications within the pharmaceutical industry. According to our AI in drug manufacturing market forecast, quality control is likely to capture the majority (36%) of the market in 2026, owing to its central role in ensuring regulatory compliance and manufacturing precision.
It is worth highlighting that the supply chain optimization segment is likely to grow at a relatively higher CAGR (29.1%), during the forecast period. This is due to the rising adoption of AI in demand forecasting, inventory management and mitigation of supply chain disruptions.

Market Share by Utility in Drug Manufacturing: Defect Defection Holds the Largest Share

This segment involves the distribution of AI in drug manufacturing market across various utilities in drug manufacturing. According to our projections, defect detection segment is likely to capture the majority (59%) share of the market in 2026, driven by the industry’s strong emphasis on minimizing batch failures and ensuring consistent product quality.

It is worth highlighting that the packaging and label inspection segment is likely to grow at a relatively higher CAGR (28.7%), during the forecast period. This is due to the strict pharmaceutical regulations regarding packaging integrity and accurate labeling, which further increases the demand for advanced inspection technologies.

Regional Analysis of AI in Drug Manufacturing Market: Asia-Pacific to Propel in the Coming Years

According to our projections, North America is likely to capture the majority (39%) of the market in 2026 and this trend is unlikely to change in the future as well. This is due to the presence of advanced pharma manufacturing infrastructure, early adoption of artificial intelligence (AI) in healthcare technologies and supportive regulatory framework across the region.
It is worth highlighting that the market in Asia-Pacific is expected to grow at a higher CAGR (29.3%), driven by the lower implementation costs, supportive government policies fostering digitalization, and rapidly expanding pharmaceutical sector.

AI in Drug Manufacturing Market: Report Deliverables

Report Deliverables	Details
Excel Data Packs (Complimentary)	Market Landscape Company Competitiveness Analysis Start-up Ecosystem Analysis Funding and Investments Analysis Partnerships and Collaborations Analysis Market Forecast and Opportunity Analysis
Key AI in Drug Manufacturing Companies Profiled	C3.AI AMD IBM Kalypso SAS Institute Körber Pharma SDG Group Catalyx Elisa Industriq Straive Axiomtek Appinventiv Amplelogic Precognize (Full list of ~130 companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization

AI in Drug Manufacturing Market Key Takeaways

The “AI in Drug Manufacturing Market: Industry Trends and Global Forecasts, till 2040” market report features an extensive study of the current market landscape, company competitiveness analysis, start-up ecosystem analysis, funding and investments analysis, partnerships and collaborations analysis, and market size and future outlook for AI in drug manufacturing market, during the forecast period.

Competitive Landscape of AI Drug Manufacturing Companies

The current market landscape features a list of around 130 players including very large, large, mid-sized and small companies. These companies have the required expertise to provide AI solutions for drug manufacturing across different geographical regions.

Notably, more than 95% of companies engaged in AI in drug manufacturing offer cutting-edge software solutions. In addition to this, close to 80% of the firms are using machine learning to digitalize different stages of drug manufacturing.

What are the Use Cases of Artificial Intelligence in Pharmaceutical Manufacturing?

Over 60% of the big pharma players are leveraging AI to transform their manufacturing processes, enhancing efficiency, quality, and agility. Key use cases include real-time monitoring, automated quality inspection, predictive maintenance, and supply chain optimization.

For instance, Sanofi uses AI to optimize production yield and process efficiency; Novartis employs machine learning algorithms for real-time plant monitoring and AI-driven supply chain optimization in drug manufacturing; Merck leverages AI to reduce false reject rates during quality inspections; and Moderna employs AI-driven tools to enhance quality control systems. These applications not only streamline operations but also contribute to cost reduction and improved regulatory landscape for AI in drug manufacturing market.

As leading pharmaceutical companies and AI solution providers continue to advance their capabilities, the integration of AI in drug manufacturing has become crucial for achieving operational excellence and maintaining a competitive edge in this rapidly evolving industry.

Market Size Analysis: What is the Opportunity for AI in Drug Manufacturing?

The global AI in drug manufacturing market size is likely to be worth $ 1.2 billion in 2026 and is expected to reach $ 34.8 billion by 2040. In terms of type of technology, computer vision segment holds the largest share of the global market given its widespread utilization in automated quality control applications across the pharmaceutical industry. Further, the market size for generative AI is likely to grow at a relatively higher CAGR during the forecast period.

Regional Analysis: Which Region Holds the Largest Share of the AI in Drug Manufacturing Market?

North America is Leading the Market

North American companies are likely to dominate the global market in 2040, with close to 40% of solution providers based in the region. This concentration of prominent industry players fuels significant investment and accelerates the adoption of AI technologies in pharmaceutical manufacturing. In addition, North America also benefits from its advanced pharmaceutical ecosystem, robust R&D capabilities, and supportive regulatory infrastructure which further contribute to its dominance.

Asia-Pacific: An Emerging Growth Spot

The market in Asia-Pacific is likely to grow at the highest CAGR (29.3%), during the forecast period till 2040. This growth is driven by several factors, including lower operational costs, government initiatives supporting digitalization, and rapidly growing pharmaceutical sector in the region. Moreover, Asia-Pacific has a relatively large number of contract manufacturing facilities, where the integration of artificial intelligence offers significant potential to enhance production efficiency, improve resource utilization, and achieve substantial reductions in operational costs.

What are the Key Drivers of Artificial Intelligence in Drug Manufacturing Market?

AI in drug manufacturing market growth is fueled by the increasing need to improve process efficiency, reduce production costs, and ensure consistent product quality in drug manufacturing. In addition, growing regulatory support and ongoing digital transformation across the pharma industry further accelerate the adoption of advanced AI solutions.

It is worth mentioning that AI solutions in drug manufacturing addresses various applications such as quality control, predictive maintenance, process development and optimization, plant / equipment performance monitoring and supply chain optimization. The expanding scope of these applications continues to drive strong market demand for AI solutions tailored to pharmaceutical manufacturing.

Key Market Trends in AI in Drug Manufacturing Market

Rising Partnerships and Collaborations amongst the Solution Providers to Foster Progress and Innovation in Expanding their Capabilities

Companies providing AI solutions for drug manufacturing have forged several partnerships with other stakeholders to enhance their technology / service portfolios. Notably, in the last five years, companies based in North America and Europe have inked more than 90% of these partnerships to strengthen their capabilities in this domain.

It is worth highlighting that, majority of the deals signed in this domain are technology integration agreements, followed by acquisitions. These deals indicate the ongoing efforts of AI solution providers to advance their offerings for pharmaceutical manufacturing.

Investment Trends in AI for Drug Manufacturing 2026

Several stakeholders in this domain have raised significant funding in order to sustain their growth initiatives. It is noteworthy that companies engaged in this domain have raised over USD 2 billion, since 2021. Additionally, majority of the funding instances were venture capital investments (69%), followed by seed funding (18%). Further, in terms of geographical activity, firms headquartered in North America have raised the majority (94%) amount in the AI in drug manufacturing industry. Notably, Dataiku emerged as the most active player (in terms of amount raised), having raised a total capital of USD 600 million since 2021 across two rounds of funding.

AI in Drug Manufacturing Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in the AI in drug manufacturing industry, across different geographies. Amongst other elements, the market report includes:

An Infographic Executive Summary
Market Landscape of AI in drug manufacturing Solution Providers
Company Competitiveness Analysis
Company Profiles
Start-up Ecosystem Analysis
Funding and Investments Analysis
Partnerships and Collaborations Analysis
Market Forecast Analysis

Glossary

Computer Vision: Computer Vision is a branch of artificial intelligence that enables computers to process and analyze visual input.
Machine Learning: Machine learning is a subset of artificial intelligence that allows a system to autonomously learn from data sets and improve over time.
Deep Learning: Deep Learning is a type of machine learning that uses artificial neural networks.
Predictive Maintenance: Predictive maintenance is a proactive approach to maintenance that uses machine learning to anticipate potential failures and schedule maintenance before they occur.

From the Author’s Desk

Author’s View on AI in Drug Manufacturing Market

AI has emerged as a cornerstone of modern pharmaceutical manufacturing with applications across the entire value chain. As companies continue to seek greater efficiency, quality and regulatory compliance, AI is going to play a central role in shaping the next generation of Pharma 4.0 manufacturing ecosystems. With real-world adoption accelerating and technologies becoming more accessible, its momentum is likely to increase further, shaping a smarter, faster and more adaptive drug manufacturing.

About Authors

Lead Author: Akarshika Singh

Lead Reviewer: Aashima Bhalla

Chief Editor: Rupali Chaudhary

+ 1. BACKGROUND

1.1. Context

1.2. Project Objectives

+ 2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.2.1. Market Landscape and Market Trends

2.2.2. Market Forecast and Opportunity Analysis

2.2.3. Comparative Analysis

2.3. Database Building

2.3.1. Project Commencement

2.3.2. Data Collection

2.3.3. Data Validation

2.3.4. Data Analysis

2.4. Project Methodology

2.4.1. Secondary Research

2.4.1.1. Annual Reports

2.4.1.2. Academic Research Papers

2.4.1.3. Company Websites

2.4.1.4. Investor Presentations

2.4.1.5. Regulatory Filings

2.4.1.6. White Papers

2.4.1.7. Industry Publications

2.4.1.8. Conferences and Seminars

2.4.1.9. Government Portals

2.4.1.10. Media and Press Releases

2.4.1.11. Newsletters

2.4.1.12. Industry Databases

2.4.1.13. Roots Proprietary Databases

2.4.1.14. Paid Databases and Sources

2.4.1.15. Social Media Portals

2.4.1.16. Other Secondary Sources

2.4.2. Primary Research

2.4.2.1. Types of Primary Research

2.4.2.1.1. Qualitative Research

2.4.2.1.2. Quantitative Research

2.4.2.1.3. Hybrid Approach

2.4.2.2. Advantages of Primary Research

2.4.2.3. Techniques for Primary Research

2.4.2.3.1. Interviews

2.4.2.3.2. Surveys

2.4.2.3.3. Focus Groups

2.4.2.3.4. Observational Research

2.4.2.3.5. Social Media Interactions

2.4.2.4. Key Opinion Leaders Considered in Primary Research

2.4.2.4.1. Company Executives (CXOs)

2.4.2.4.2. Board of Directors

2.4.2.4.3. Company Presidents and Vice Presidents

2.4.2.4.4. Research and Development Heads

2.4.2.4.5. Technical Experts

2.4.2.4.6. Subject Matter Experts

2.4.2.4.7. Scientists

2.4.2.4.8. Doctors and Other Healthcare Providers

2.4.2.5. Ethics and Integrity

2.4.2.5.1. Research Ethics

2.4.2.5.2. Data Integrity

2.4.3. Analytical Tools and Databases

2.5. Robust Quality Control

+ 3. MARKET DYNAMICS

3.1. Chapter Overview

3.2. Forecast Methodology

3.2.1. Top-down Approach

3.2.2. Bottom-up Approach

3.2.3. Hybrid Approach

3.3. Market Assessment Framework

3.3.1. Total Addressable Market (TAM)

3.3.2. Serviceable Addressable Market (SAM)

3.3.3. Serviceable Obtainable Market (SOM)

3.3.4. Currently Acquired Market (CAM)

3.4. Forecasting Tools and Techniques

3.4.1. Qualitative Forecasting

3.4.2. Correlation

3.4.3. Regression

3.4.4. Extrapolation

3.4.5. Convergence

3.4.6. Sensitivity Analysis

3.4.7. Scenario Planning

3.4.8. Data Visualization

3.4.9. Time Series Analysis

3.4.10. Forecast Error Analysis

3.5. Key Considerations

3.5.1. Demographics

3.5.2. Government Regulations

3.5.3. Reimbursement Scenarios

3.5.4. Market Access

3.5.5. Supply Chain

3.5.6. Industry Consolidation

3.5.7. Pandemic / Unforeseen Disruptions Impact

3.6. Limitations

+ 4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview

4.2. Market Dynamics

4.2.1. Time Period

4.2.1.1. Historical Trends

4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage

4.2.2.1. Major Currencies Affecting the Market

4.2.2.2. Factors Affecting Currency Fluctuations on the Industry

4.2.2.3. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Currency Exchange Rate

4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market

4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession

4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt

4.2.5. Inflation

4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates

4.2.6.1. Interest Rates and Their Impact on the Market

4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis

4.2.7.1. Type of Commodity

4.2.7.2. Origins and Destinations

4.2.7.3. Values and Weights

4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics

4.2.8.1. Import Scenario

4.2.8.2. Export Scenario

4.2.8.3. Trade Policies

4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers

4.2.8.5. Impact of Trade Barriers on the Market

4.2.9. War Impact Analysis

4.2.9.1. Russian-Ukraine War

4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors

4.2.10.1. Global Economic Impact

4.2.10.2. Industry-specific Impact

4.2.10.3. Government Response and Stimulus Measures

4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators

4.2.11.1. Fiscal Policy

4.2.11.2. Consumer Spending

4.2.11.3. Gross Domestic Product

4.2.11.4. Employment

4.2.11.5. Taxes

4.2.11.6. Stock Market Performance

4.2.11.7. Cross Border Dynamics

4.3. Conclusion

+ 5. EXECUTIVE SUMMARY

+ 6. INTRODUCTION

6.1. Overview of AI in Drug Manufacturing

6.2. Need for AI in Drug Manufacturing

6.3. Role of AI across the Drug Manufacturing Value Chain

6.4. Types of AI Technology used in Drug Manufacturing

6.5. Applications of AI in Drug Manufacturing

6.6. Advantages of AI in Drug Manufacturing

6.7. Challenges Associated with AI Adoption in Drug Manufacturing

6.8. Recent Developments and Future Perspectives

+ 7. MARKET LANDSCAPE: AI IN DRUG MANUFACTURING SOLUTION PROVIDERS

7.1. Methodology and Key Parameters

7.2. AI in Drug Manufacturing: Market Landscape

7.2.1. Analysis by Year of Establishment

7.2.2. Analysis by Company Size

7.2.3. Analysis by Location of Headquarters (Region)

7.2.4. Analysis by Location of Headquarters (Country)

7.2.5. Analysis by Company Ownership

7.2.6. Analysis by Type of Company

7.2.7. Analysis by Type of AI Solution

7.2.8. Analysis by Type of Offering

7.2.9. Analysis by Type of Technology

7.2.10. Analysis by Mode of Deployment

7.2.11. Analysis by Application Area

7.2.12. Analysis by Utility in Drug Manufacturing

+ 8. COMPANY COMPETITIVENESS ANALYSIS

8.1. Methodology and Key Parameters

8.2. Scoring Criteria

8.3. Overview of Peer Groups

8.4. AI in Drug Manufacturing: Company Competitiveness Analysis

8.4.1. AI in Drug Manufacturing Solution Providers in North America: Peer Group I

8.4.1.1. Leading Players in Peer Group I

8.4.2. AI in Drug Manufacturing Solution Providers in Europe: Peer Group II

8.4.2.1. Leading Players in Peer Group II

8.4.3. AI in Drug Manufacturing Solution Providers in Asia-Pacific and Rest of the World: Peer Group III

8.4.3.1. Leading Players in Peer Group III

8.5. AI in Drug Manufacturing: Benchmarking Analysis

8.5.1. Benchmarking based on Supplier Strength Score

8.5.2. Benchmarking based on Technology Strength Score

8.5.3. Benchmarking based on Application Diversity Score

+ 9. COMPANY PROFILES: AI IN DRUG MANUFACTURING SOLUTION PROVIDERS IN NORTH AMERICA

9.1. Overview

9.2. C3.AI

9.2.1. Company Details

9.2.2. Technology Portfolio

9.2.3. Financial Information

9.2.4. SWOT Analysis

9.2.5. Strategic Framework

9.2.6. Future Outlook

9.3. AMD

9.4. IBM

9.5. Kalypso: A Rockwell Automation Business

9.6. SAS Institute

+ 10. COMPANY PROFILES: AI IN DRUG MANUFACTURING SOLUTION PROVIDERS IN EUROPE

10.1. Overview

10.2. Körber Pharma

10.2.1. Company Details

10.2.2. Technology Portfolio

10.2.3. Financial Information

10.2.4. SWOT Analysis

10.2.5. Strategic Framework

10.2.6. Future Outlook

10.3. SDG Group

10.4. Catalyx

10.5. Elisa Industriq

+ 11. COMPANY PROFILES: AI IN DRUG MANUFACTURING SOLUTION PROVIDERS IN ASIA-PACIFIC AND REST OF THE WORLD

11.1. Overview

11.2. Straive

11.2.1. Company Details

11.2.2. Technology Portfolio

11.2.3. SWOT Analysis

11.2.4. Strategic Framework

11.2.5. Future Outlook

11.3. Axiomtek

11.4. Appinventiv

11.5. Amplelogic

11.6. Samson Precognize Solutions

+ 12. PARTNERSHIPS AND COLLABORATIONS

12.1. Partnership Models

12.2. AI in Drug Manufacturing: Partnerships and Collaborations

12.2.1. Analysis by Year of Partnership

12.2.2. Analysis by Type of Partnership

12.2.3. Analysis by Year and Type of Partnership

12.2.4. Analysis by Type of Partner

12.2.5. Analysis by Geographical Activity

12.2.5.1. Local and International Deals

12.2.5.2. Intracontinental and Intercontinental Deals

12.2.6. Most Active Players: Analysis by Number of Partnerships

+ 13. FUNDING AND INVESTMENT ANALYSIS

13.1. Funding Models

13.2. Funding Lifecycle Analysis

13.3. Investment Case: Risk and Return

13.4. AI in Drug Manufacturing: Funding and Investment Analysis

13.4.1. Analysis of Instances by Year of Funding

13.4.2. Analysis of Instances by Type of Funding

13.4.3. Analysis of Instances by Year and Type of Funding

13.4.4. Analysis of Amount Raised by Year of funding

13.4.5. Analysis of Amount Raised by Type of Funding

13.4.6. Analysis by Geography

13.4.7. Most Active Players: Analysis by Number of Funding Instances

13.4.8. Most Active Players: Analysis by Amount Raised

13.4.9. Leading Investors: Analysis by Number of Funding Instances

13.5. Evolution and Relative Assessment of Funding Models

13.5.1. Grants / Awards

13.5.2. Venture Capital

13.5.3. Private Placement

13.6. Summary of Funding and Investment Opportunities

+ 14. START-UP HEALTH INDEXING

14.1. Chapter Overview

14.2. Start-ups Offering AI Solutions for Drug Manufacturing

14.2.1. Analysis by Location of Headquarters

14.3. Benchmarking of Start-ups

14.3.1. Analysis by Technology Strength

14.3.2. Analysis by Application Diversity

14.3.3. Analysis by Utility in Drug Manufacturing

14.3.4. Analysis by Funding Activity

14.3.5. Analysis by Revenue

14.3.6. Start-up Health Indexing: Roots Analysis Perspective

+ 15. AI IN DRUG MANUFACTURING MARKET: MEGATRENDS ANALYSIS

15.1. Megatrends Analysis: An Overview of Emerging Trends

15.1.1. Pharma 4.0 Adoption

15.1.2. Increasing Emphasis on Regulatory Compliance

15.1.3. Transition towards Continuous Manufacturing

15.1.4. Digitization of Batch Records and Manufacturing Documentation

15.1.5. Shift towards Predictive Maintenance Approach

15.1.6. Rise in Strategic Collaborations and Investments

+ 16. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

16.1. Chapter Overview

16.2. Market Drivers

16.3. Market Restraints

16.4. Market Opportunities

16.5. Market Challenges

16.6. Conclusion

+ 17. GLOBAL AI IN DRUG MANUFACTURING MARKET

17.1. Methodology

17.2. AI in Drug Manufacturing Market, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

17.2.1. Multivariate Scenario Analysis

17.2.1.1. Conservative Scenario

17.2.1.2. Optimistic Scenario

17.3. Key Market Segmentations

17.4. Key Assumptions and Data Validation

+ 18. AI IN DRUG MANUFACTURING MARKET, BY TYPE OF OFFERING

18.1. Methodology

18.2. AI in Drug Manufacturing Market: Distribution by Type of Offering

18.2.1. AI in Drug Manufacturing Market for Software, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

18.2.2. AI in Drug Manufacturing Market for Hardware, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

18.2.3. AI in Drug Manufacturing Market for Services, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

18.3. Data Triangulation and Validation

+ 19. AI IN DRUG MANUFACTURING MARKET, BY MODE OF DEPLOYMENT

19.1. Methodology

19.2. AI in Drug Manufacturing Market: Distribution by Mode of Deployment

19.2.1. AI in Drug Manufacturing Market for Cloud-based Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

19.2.2. AI in Drug Manufacturing Market for On-premise Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

19.3. Data Triangulation and Validation

+ 20. AI IN DRUG MANUFACTURING MARKET, BY TYPE OF AI SOLUTIONS

20.1. Methodology

20.2. AI in Drug Manufacturing Market: Distribution by Type of AI Solution

20.2.1. AI in Drug Manufacturing Market for Off-the-Shelf AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

20.2.2. AI in Drug Manufacturing Market for Personalized AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

20.3. Data Triangulation and Validation

+ 21. AI IN DRUG MANUFACTURING MARKET, BY TYPE OF TECHNOLOGY

21.1. Methodology

21.2. AI in Drug Manufacturing Market: Distribution by Type of Technology

21.2.1. AI in Drug Manufacturing Market for Computer Vision, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

21.2.2. AI in Drug Manufacturing Market for Machine Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

21.2.3. AI in Drug Manufacturing Market for Deep Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

21.2.4. AI in Drug Manufacturing Market for Generative AI, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

21.2.5. AI in Drug Manufacturing Market for Other Technologies, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

21.3. Data Triangulation and Validation

+ 22. AI IN DRUG MANUFACTURING MARKET, BY APPLICATION AREA

22.1. Methodology

22.2. AI in Drug Manufacturing Market: Distribution by Application Area

22.2.1. AI in Drug Manufacturing Market for Quality Control, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

22.2.2. AI in Drug Manufacturing Market for Predictive Maintenance, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

22.2.3. AI in Drug Manufacturing Market for Process Development and Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

22.2.4. AI in Drug Manufacturing Market for Plant or Equipment Performance Monitoring, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

22.2.5. AI in Drug Manufacturing Market for Supply Chain Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

22.2.6. AI in Drug Manufacturing Market for Other Application Areas, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

22.3. Data Triangulation and Validation

+ 23. AI IN DRUG MANUFACTURING MARKET, BY UTILITY IN DRUG MANUFACTURING

23.1. Methodology

23.2. AI in Drug Manufacturing Market: Distribution by Utility in Drug Manufacturing

23.2.1. AI in Drug Manufacturing Market for Defect Detection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

23.2.2. AI in Drug Manufacturing Market for Packaging and Label Inspection, Historical Trends (since 2023) and Forecasted Estimates (till 2040)

23.2.3. AI in Drug Manufacturing Market for Package Counting, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

23.2.4. AI in Drug Manufacturing Market for Fill Level Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

23.2.5. AI in Drug Manufacturing Market for Other Utilities, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

23.3. Data Triangulation and Validation

+ 24. AI IN DRUG MANUFACTURING MARKET, BY GEOGRAPHICAL REGIONS

24.1. Methodology

24.2. AI in Drug Manufacturing Market: Distribution by Geographical Regions

24.2.1. AI in Drug Manufacturing Market in North America, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.1.1. AI in Drug Manufacturing Market in the US, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.1.2. AI in Drug Manufacturing Market in Canada, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.2. AI in Drug Manufacturing Market in Europe, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.2.1. AI in Drug Manufacturing Market in Germany, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.2.2. AI in Drug Manufacturing Market in France, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.2.3. AI in Drug Manufacturing Market in Spain, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.2.4. AI in Drug Manufacturing Market in Italy, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.2.5. AI in Drug Manufacturing Market in the UK, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.2.6. AI in Drug Manufacturing Market in the Rest of Europe, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.3. AI in Drug Manufacturing Market in Asia-Pacific, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.3.1. AI in Drug Manufacturing Market in Australia, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.3.2. AI in Drug Manufacturing Market in China, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.3.3. AI in Drug Manufacturing Market in Japan, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.3.4. AI in Drug Manufacturing Market in India, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.3.5. AI in Drug Manufacturing Market in South Korea, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.3.6. AI in Drug Manufacturing Market in the Rest of Asia-Pacific, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.4. AI in Drug Manufacturing Market in the Middle East and North Africa, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.4.1. AI in Drug Manufacturing Market in Saudi Arabia, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.4.2. AI in Drug Manufacturing Market in UAE, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.4.3. AI in Drug Manufacturing Market in Egypt, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.4.4. AI in Drug Manufacturing Market in the Rest of Middle East and North Africa, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.5. AI in Drug Manufacturing Market in Latin America, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.5.1. AI in Drug Manufacturing Market in Brazil, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.5.2. AI in Drug Manufacturing Market in Argentina, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.2.5.3. AI in Drug Manufacturing Market in the Rest of Latin America, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

24.3. AI in Drug Manufacturing Market, By Geographical Regions: Market Dynamics Assessment

24.3.1. Penetration-Growth (P-G) Matrix

24.3.2. Market Movement Analysis

+ 25. AI IN DRUG MANUFACTURING MARKET, BY KEY PLAYERS

+ 26. MARKET OPPORTUNITY ANALYSIS: NORTH AMERICA

26.1. AI in Drug Manufacturing Market in North America: Distribution by Type of Offering

26.1.1. AI in Drug Manufacturing Market in North America for Software, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.1.2. AI in Drug Manufacturing Market in North America for Hardware, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.1.3. AI in Drug Manufacturing Market in North America for Services, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.2. AI in Drug Manufacturing Market in North America: Distribution by Type of AI Solution

26.2.1. AI in Drug Manufacturing Market in North America for Off-the-Shelf AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.2.2. AI in Drug Manufacturing Market in North America for Personalized AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.3. AI in Drug Manufacturing Market in North America: Distribution by Mode of Deployment

26.3.1. AI in Drug Manufacturing Market in North America Cloud-based Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.3.2. AI in Drug Manufacturing Market in North America for On-premise Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.4. AI in Drug Manufacturing Market in North America: Distribution by Type of Technology

26.4.1. AI in Drug Manufacturing Market in North America for Computer Vision, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.4.2. AI in Drug Manufacturing Market in North America for Machine Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.4.3. AI in Drug Manufacturing Market in North America for Deep Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.4.4. AI in Drug Manufacturing Market in North America for Generative AI, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.4.5. AI in Drug Manufacturing Market in North America for Other Technologies, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.5. AI in Drug Manufacturing Market in North America: Distribution by Application Area

26.5.1. AI in Drug Manufacturing Market in North America for Quality Control, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.5.2. AI in Drug Manufacturing Market in North America for Predictive Maintenance, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.5.3. AI in Drug Manufacturing Market in North America for Process Development and Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.5.4. AI in Drug Manufacturing Market in North America for Supply Chain Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.5.5. AI in Drug Manufacturing Market in North America for Other Application Areas, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.6. AI in Drug Manufacturing Market in North America: Distribution by Utility in Drug Manufacturing

26.6.1. AI in Drug Manufacturing Market in North America for Defect Detection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.6.2. AI in Drug Manufacturing Market in North America for Packaging and Label Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.6.3. AI in Drug Manufacturing Market in North America for Package Counting, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.6.4. AI in Drug Manufacturing Market in North America for Fill Level Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

26.6.5. AI in Drug Manufacturing Market in North America for Other Utilities, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

+ 27. MARKET OPPORTUNITY ANALYSIS: EUROPE

27.1. AI in Drug Manufacturing Market in Europe: Distribution by Type of Offering

27.1.1. AI in Drug Manufacturing Market in Europe for Software, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.1.2. AI in Drug Manufacturing Market in Europe for Hardware, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.1.3. AI in Drug Manufacturing Market in Europe for Services, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.2. AI in Drug Manufacturing Market in Europe: Distribution by Type of AI Solution

27.2.1. AI in Drug Manufacturing Market in Europe for Off-the-Shelf AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.2.2. AI in Drug Manufacturing Market in Europe for Personalized AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.3. AI in Drug Manufacturing Market in Europe: Distribution by Mode of Deployment

27.3.1. AI in Drug Manufacturing Market in Europe Cloud-based Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.3.2. AI in Drug Manufacturing Market in Europe for On-premise Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.4. AI in Drug Manufacturing Market in Europe: Distribution by Type of Technology

27.4.1. AI in Drug Manufacturing Market in Europe for Computer Vision, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.4.2. AI in Drug Manufacturing Market in Europe for Machine Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.4.3. AI in Drug Manufacturing Market in Europe for Deep Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.4.4. AI in Drug Manufacturing Market in Europe for Generative AI, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.4.5. AI in Drug Manufacturing Market in Europe for Other Technologies, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.5. AI in Drug Manufacturing Market in Europe: Distribution by Application Area

27.5.1. AI in Drug Manufacturing Market in Europe for Quality Control, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.5.2. AI in Drug Manufacturing Market in Europe for Predictive Maintenance, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.5.3. AI in Drug Manufacturing Market in Europe for Process Development and Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.5.4. AI in Drug Manufacturing Market in Europe for Supply Chain Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.5.5. AI in Drug Manufacturing Market in Europe for Other Application Areas, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.6. AI in Drug Manufacturing Market in Europe: Distribution by Utility in Drug Manufacturing

27.6.1. AI in Drug Manufacturing Market in Europe for Defect Detection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.6.2. AI in Drug Manufacturing Market in Europe for Packaging and Label Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.6.3. AI in Drug Manufacturing Market in Europe for Package Counting, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.6.4. AI in Drug Manufacturing Market in Europe for Fill Level Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

27.6.5. AI in Drug Manufacturing Market in Europe for Other Utilities, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

+ 28. MARKET OPPORTUNITY ANALYSIS: ASIA-PACIFIC

28.1. AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Type of Offering

28.1.1. AI in Drug Manufacturing Market in Asia-Pacific for Software, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.1.2. AI in Drug Manufacturing Market in Asia-Pacific for Hardware, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.1.3. AI in Drug Manufacturing Market in Asia-Pacific for Services, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.2. AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Type of AI Solution

28.2.1. AI in Drug Manufacturing Market in Asia-Pacific for Off-the-Shelf AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.2.2. AI in Drug Manufacturing Market in Asia-Pacific for Personalized AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.3. AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Mode of Deployment

28.3.1. AI in Drug Manufacturing Market in Asia-Pacific Cloud-based Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.3.2. AI in Drug Manufacturing Market in Asia-Pacific for On-premise Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.4. AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Type of Technology

28.4.1. AI in Drug Manufacturing Market in Asia-Pacific for Computer Vision, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.4.2. AI in Drug Manufacturing Market in Asia-Pacific for Machine Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.4.3. AI in Drug Manufacturing Market in Asia-Pacific for Deep Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.4.4. AI in Drug Manufacturing Market in Asia-Pacific for Generative AI, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.4.5. AI in Drug Manufacturing Market in Asia-Pacific for Other Technologies, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.5. AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Application Area

28.5.1. AI in Drug Manufacturing Market in Asia-Pacific for Quality Control, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.5.2. AI in Drug Manufacturing Market in Asia-Pacific for Predictive Maintenance, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.5.3. AI in Drug Manufacturing Market in Asia-Pacific for Process Development and Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.5.4. AI in Drug Manufacturing Market in Asia-Pacific for Supply Chain Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.5.5. AI in Drug Manufacturing Market in Asia-Pacific for Other Application Areas, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.6. AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Utility in Drug Manufacturing

28.6.1. AI in Drug Manufacturing Market in Asia-Pacific for Defect Detection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.6.2. AI in Drug Manufacturing Market in Asia-Pacific for Packaging and Label Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.6.3. AI in Drug Manufacturing Market in Asia-Pacific for Package Counting, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.6.4. AI in Drug Manufacturing Market in Asia-Pacific for Fill Level Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

28.6.5. AI in Drug Manufacturing Market in Asia-Pacific for Other Utilities, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

+ 29. MARKET OPPORTUNITY ANALYSIS: MIDDLE EAST AND NORTH AFRICA

29.1. AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Type of Offering

29.1.1. AI in Drug Manufacturing Market in Middle East and North Africa for Software, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.1.2. AI in Drug Manufacturing Market in Middle East and North Africa for Hardware, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.1.3. AI in Drug Manufacturing Market in Middle East and North Africa for Services, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.2. AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Type of AI Solution

29.2.1. AI in Drug Manufacturing Market in Middle East and North Africa for Off-the-Shelf AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.2.2. AI in Drug Manufacturing Market in Middle East and North Africa for Personalized AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.3. AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Mode of Deployment

29.3.1. AI in Drug Manufacturing Market in Middle East and North Africa Cloud-based Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.3.2. AI in Drug Manufacturing Market in Middle East and North Africa for On-premise Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.4. AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Type of Technology

29.4.1. AI in Drug Manufacturing Market in Middle East and North Africa for Computer Vision, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.4.2. AI in Drug Manufacturing Market in Middle East and North Africa for Machine Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.4.3. AI in Drug Manufacturing Market in Middle East and North Africa for Deep Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.4.4. AI in Drug Manufacturing Market in Middle East and North Africa for Generative AI, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.4.5. AI in Drug Manufacturing Market in Middle East and North Africa for Other Technologies, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.5. AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Application Area

29.5.1. AI in Drug Manufacturing Market in Middle East and North Africa for Quality Control, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.5.2. AI in Drug Manufacturing Market in Middle East and North Africa for Predictive Maintenance, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.5.3. AI in Drug Manufacturing Market in Middle East and North Africa for Process Development and Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.5.4. AI in Drug Manufacturing Market in Middle East and North Africa for Supply Chain Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.5.5. AI in Drug Manufacturing Market in Middle East and North Africa for Other Application Areas , Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.6. AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Utility in Drug Manufacturing

29.6.1. AI in Drug Manufacturing Market in Middle East and North Africa for Defect Detection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.6.2. AI in Drug Manufacturing Market in Middle East and North Africa for Packaging and Label Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.6.3. AI in Drug Manufacturing Market in Middle East and North Africa for Package Counting, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.6.4. AI in Drug Manufacturing Market in Middle East and North Africa for Fill Level Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

29.6.5. AI in Drug Manufacturing Market in Middle East and North Africa for Other Utilities, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

+ 30. MARKET OPPORTUNITY ANALYSIS: LATIN AMERICA

30.1. AI in Drug Manufacturing Market in Latin America: Distribution by Type of Offering

30.1.1. AI in Drug Manufacturing Market in Latin America for Software, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.1.2. AI in Drug Manufacturing Market in Latin America for Hardware, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.1.3. AI in Drug Manufacturing Market in Latin America for Services, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.2. AI in Drug Manufacturing Market in Latin America: Distribution by Type of AI Solution

30.2.1. AI in Drug Manufacturing Market in Latin America for Off-the-Shelf AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.2.2. AI in Drug Manufacturing Market in Latin America for Personalized AI Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.3. AI in Drug Manufacturing Market in Latin America: Distribution by Mode of Deployment

30.3.1. AI in Drug Manufacturing Market in Latin America Cloud-based Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.3.2. AI in Drug Manufacturing Market in Latin America for On-premise Solutions, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.4. AI in Drug Manufacturing Market in Latin America: Distribution by Type of Technology

30.4.1. AI in Drug Manufacturing Market in Latin America for Computer Vision, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.4.2. AI in Drug Manufacturing Market in Latin America for Machine Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.4.3. AI in Drug Manufacturing Market in Latin America for Deep Learning, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.4.4. AI in Drug Manufacturing Market in Latin America for Generative AI, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.4.5. AI in Drug Manufacturing Market in Latin America for Other Technologies, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.5. AI in Drug Manufacturing Market in Latin America: Distribution by Application Area

30.5.1. AI in Drug Manufacturing Market in Latin America for Quality Control, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.5.2. AI in Drug Manufacturing Market in Latin America for Predictive Maintenance, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.5.3. AI in Drug Manufacturing Market in Latin America for Process Development and Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.5.4. AI in Drug Manufacturing Market in Latin America for Supply Chain Optimization, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.5.5. AI in Drug Manufacturing Market in Latin America for Other Application Areas, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.6. AI in Drug Manufacturing Market in Latin America: Distribution by Utility in Drug Manufacturing

30.6.1. AI in Drug Manufacturing Market in Latin America for Defect Detection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.6.2. AI in Drug Manufacturing Market in Latin America for Packaging and Label Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.6.3. AI in Drug Manufacturing Market in Latin America for Package Counting, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.6.4. AI in Drug Manufacturing Market in Latin America for Fill Level Inspection, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

30.6.5. AI in Drug Manufacturing Market in Latin America for Other Utilities, Historical Trends (since 2021) and Forecasted Estimates (till 2040)

+ 31. CONCLUDING INSIGHTS

+ 32. EXECUTIVE INSIGHTS

+ 33. TABULATED DATA

+ 34. LIST OF COMPANIES AND ORGANIZATIONS

+ List of Figures

Figure 2.1 Research Methodology: Project Methodology

Figure 2.2 Research Methodology: Data Sources for Secondary Research

Figure 2.3 Research Methodology: Robust Quality Control

Figure 3.1 Market Dynamics: Forecast Methodology

Figure 3.2 Market Dynamics: Market Assessment Framework

Figure 3.3 Market Dynamics: Example List of Parameters

Figure 4.1 Historical Analysis of Past Recessions and Lessons Learnt

Figure 5.1 Executive Summary: Market Landscape

Figure 5.2 Executive Summary: Market Trends

Figure 5.3 Executive Summary: Market Forecast and Opportunity Analysis

Figure 6.1 Types of AI Technology used in Drug Manufacturing

Figure 6.2 Applications of AI in Drug Manufacturing

Figure 6.3 Challenges Associated with AI Adoption in Drug Manufacturing

Figure 6.4 Future Perspectives

Figure 7.1 AI in Drug Manufacturing Market: Distribution by Year of Establishment

Figure 7.2 AI in Drug Manufacturing Market: Distribution by Company Size

Figure 7.3 AI in Drug Manufacturing Market: Distribution by Location of Headquarters (Region)

Figure 7.4 AI in Drug Manufacturing Market: Distribution by Location of Headquarters (Country)

Figure 7.5 AI in Drug Manufacturing Market: Distribution by Company Ownership

Figure 7.6 AI in Drug Manufacturing Market: Distribution by Type of Company

Figure 7.7 AI in Drug Manufacturing Market: Distribution by Type of AI Solution

Figure 7.8 AI in Drug Manufacturing Market: Distribution by Type of Offering

Figure 7.9 AI in Drug Manufacturing Market: Distribution by Type of Technology

Figure 7.10 AI in Drug Manufacturing Market: Distribution by Mode of Deployment

Figure 7.11 AI in Drug Manufacturing Market: Distribution by Application Area

Figure 7.12 AI in Drug Manufacturing Market: Distribution by Utility in Drug Manufacturing

Figure 8.1 Company Competitiveness Analysis: AI in Drug Manufacturing Solution Providers in North America (Peer Group I)

Figure 8.2 Company Competitiveness Analysis: AI in Drug Manufacturing Solution Providers in Europe (Peer Group II)

Figure 8.3 Company Competitiveness Analysis: AI in Drug Manufacturing Solution Providers in Asia-Pacific and Rest of the World (Peer Group III)

Figure 8.4 Company Competitiveness Analysis: Benchmarking of Supplier Strength Score

Figure 8.5 Company Competitiveness Analysis: Benchmarking of Technology Strength Score

Figure 8.6 Company Competitiveness Analysis: Benchmarking of Application Diversity Score

Figure 9.1 C3.AI: Technology Portfolio

Figure 9.2 C3.AI: Consolidated Financial Details, Since FY 2021 (USD Million)

Figure 9.3 C3.AI: SWOT Analysis

Figure 9.4 C3.AI: Strategic Framework

Figure 9.5 AMD: Technology Portfolio

Figure 9.6 AMD: Consolidated Financial Details, Since FY 2021 (USD Million)

Figure 9.7 AMD: SWOT Analysis

Figure 9.8 AMD: Strategic Framework

Figure 9.9 IBM: Technology Portfolio

Figure 9.10 IBM: Consolidated Financial Details, Since FY 2021 (USD Million)

Figure 9.11 IBM: SWOT Analysis

Figure 9.12 IBM: Strategic Framework

Figure 9.13 Kalypso: A Rockwell Automation Business: Technology Portfolio

Figure 9.14 Kalypso: A Rockwell Automation Business: Consolidated Financial Details, Since FY 2021 (USD Million)

Figure 9.15 Kalypso: A Rockwell Automation Business: SWOT Analysis

Figure 9.16 Kalypso: A Rockwell Automation Business: Strategic Framework

Figure 9.17 SAS Institute: Technology Portfolio

Figure 9.18 SAS Institute: Consolidated Financial Details, Since FY 2021 (USD Million)

Figure 9.19 SAS Institute: SWOT Analysis

Figure 9.20 SAS Institute: Strategic Framework

Figure 10.1 Körber Pharma: Technology Portfolio

Figure 10.2 Körber Pharma: Consolidated Financial Details, Since FY 2021 (USD Million)

Figure 10.3 Körber Pharma: SWOT Analysis

Figure 10.4 Körber Pharma: Strategic Framework

Figure 10.5 SDG Group: Technology Portfolio

Figure 10.6 SDG Group: SWOT Analysis

Figure 10.7 SDG Group: Strategic Framework

Figure 10.8 Catalyx: Technology Portfolio

Figure 10.9 Catalyx: SWOT Analysis

Figure 10.10 Catalyx: Strategic Framework

Figure 10.11 Elisa Industriq: Technology Portfolio

Figure 10.12 Elisa Industriq: Consolidated Financial Details, Since FY 2021 (USD Million)

Figure 10.13 Elisa Industriq: SWOT Analysis

Figure 10.14 Elisa Industriq: Strategic Framework

Figure 11.1 Straive : Technology Portfolio

Figure 11.2 Straive : SWOT Analysis

Figure 11.3 Straive : Strategic Framework

Figure 11.4 Axiomtek: Technology Portfolio

Figure 11.5 Axiomtek: Consolidated Financial Details, Since FY 2021 (USD Million)

Figure 11.6 Axiomtek: SWOT Analysis

Figure 11.7 Axiomtek: Strategic Framework

Figure 11.8 Appinventiv: Technology Portfolio

Figure 11.9 Appinventiv: SWOT Analysis

Figure 11.10 Appinventiv: Strategic Framework

Figure 11.11 Amplelogic: Technology Portfolio

Figure 11.12 Amplelogic: SWOT Analysis

Figure 11.13 Amplelogic: Strategic Framework

Figure 11.14 Samson Precognize Solutions: Technology Portfolio

Figure 11.15 Samson Precognize Solutions: SWOT Analysis

Figure 11.16 Samson Precognize Solutions: Strategic Framework

Figure 12.1 Partnerships and Collaborations: Distribution by Year of Partnership

Figure 12.2 Partnerships and Collaborations: Distribution by Type of Partnership

Figure 12.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership

Figure 12.4 Partnerships and Collaborations: Distribution by Type of Partner

Figure 12.5 Partnerships and Collaborations: Distribution by Geographical Activity

Figure 12.6 Partnerships and Collaborations: Local and International Deals

Figure 12.7 Partnerships and Collaborations: Intracontinental and Intercontinental Deals

Figure 12.8 Most Active Players: Distribution by Number of Partnerships

Figure 13.1 Funding and Investments: Cumulative Year-wise Trend of Funding and Investments

Figure 13.2 Funding and Investments: Distribution of Funding Instances by Type of Funding

Figure 13.3 Funding and Investments: Year-wise Distribution of Funding Instances by Type of Funding

Figure 13.4 Funding and Investments: Distribution of Amount Invested by Type of Funding

Figure 13.5 Funding and Investments: Distribution of Funding Instances by Geography

Figure 13.6 Most Active Players: Distribution by Funding Instances

Figure 13.7 Most Active Players: Distribution by Amount Raised (USD Million)

Figure 13.8 Leading Investors: Distribution by Number of Funding Instances

Figure 13.9 Funding and Investments: Summary

Figure 14.1 Start-up Health Indexing: Distribution by Location of Headquarters

Figure 14.2 Start-up Health Indexing: Distribution by Technology Strength

Figure 14.3 Start-up Health Indexing: Distribution by Application Diversity

Figure 14.4 Start-up Health Indexing: Distribution by Utility in Drug Manufacturing

Figure 14.5 Start-up Health Indexing: Distribution by Funding Activity

Figure 14.6 Start-up Health Indexing: Distribution by Revenue

Figure 14.7 Start-up Health Indexing: Roots Analysis Perspective

Figure 14.8 Leading Start-ups: Spider Web Analysis

Figure 15.1 AI in Drug Manufacturing Market: An Overview of Emerging Trends

Figure 16.1 AI in Drug Manufacturing: Growth Drivers

Figure 16.2 AI in Drug Manufacturing: Market Restraints

Figure 16.3 AI in Drug Manufacturing: Market Opportunities

Figure 16.4 AI in Drug Manufacturing: Market Challenges

Figure 17.1 Global AI in Drug Manufacturing Market, Historical Trends (since 2021) and Forecasted Estimated (till 2040) (USD Billion)

Figure 17.2 Global AI in Drug Manufacturing Market, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative Scenario (USD Billion)

Figure 17.3 Global AI in Drug Manufacturing Market, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Optimistic Scenario (USD Billion)

Figure 18.1 AI in Drug Manufacturing Market: Distribution by Type of Offering

Figure 18.2 AI in Drug Manufacturing Market for Hardware, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 18.3 AI in Drug Manufacturing Market for Software, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 18.4 AI in Drug Manufacturing Market for Services, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 19.1 AI in Drug Manufacturing Market: Distribution by Mode pf Deployment

Figure 19.2 AI in Drug Manufacturing Market for Cloud-based AI Solutions, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 19.3 AI in Drug Manufacturing Market for On-premise AI Solutions, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 20.1 AI in Drug Manufacturing Market: Distribution by Type of AI Solution

Figure 20.2 AI in Drug Manufacturing Market for Off-the-Shelf AI Solutions, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 20.3 AI in Drug Manufacturing Market Personalized AI Solutions, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 21.1 AI in Drug Manufacturing Market: Distribution by Type of Technology

Figure 21.2 AI in Drug Manufacturing Market for Computer Vision, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 21.3 AI in Drug Manufacturing Market for Machine Learning, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 21.4 AI in Drug Manufacturing Market for Deep Learning, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 21.5 AI in Drug Manufacturing Market for Generative AI, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 21.6 AI in Drug Manufacturing Market for Other Technologies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 22.1 AI in Drug Manufacturing Market: Distribution by Application Area

Figure 22.2 AI in Drug Manufacturing Market for Quality Control, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 22.3 AI in Drug Manufacturing Market for Predictive Maintenance, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 22.4 AI in Drug Manufacturing Market for Process Development and Optimization, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 22.5 AI in Drug Manufacturing Market for Plant or Equipment Performance Monitoring, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 22.6 AI in Drug Manufacturing Market for Supply Chain Optimization, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 22.7 AI in Drug Manufacturing Market for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 23.1 AI in Drug Manufacturing Market: Distribution by Utility in Drug Manufacturing

Figure 23.2 AI in Drug Manufacturing Market for Defect Detection, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 23.3 AI in Drug Manufacturing Market for Packaging and Label Inspection, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 23.4 AI in Drug Manufacturing Market for Package Counting, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 23.5 AI in Drug Manufacturing Market for Fill Level Inspection, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 23.6 AI in Drug Manufacturing Market for Other Utilities, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.1 AI in Drug Manufacturing Market: Distribution by Geographical Regions

Figure 24.2 AI in Drug Manufacturing Market in North America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.3 AI in Drug Manufacturing Market in the US, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.4 AI in Drug Manufacturing Market in Canada, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.5 AI in Drug Manufacturing Market in Europe, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.6 AI in Drug Manufacturing Market in Germany, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.7 AI in Drug Manufacturing Market in France, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.8 AI in Drug Manufacturing Market in Spain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.9 AI in Drug Manufacturing Market in Italy, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.10 AI in Drug Manufacturing Market in the UK, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.11 AI in Drug Manufacturing Market in Rest of Europe, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.12 AI in Drug Manufacturing Market in Asia-Pacific, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.13 AI in Drug Manufacturing Market in Australia, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.14 AI in Drug Manufacturing Market in China, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.15 AI in Drug Manufacturing Market in Japan, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.16 AI in Drug Manufacturing Market in India, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.17 AI in Drug Manufacturing Market in South Korea, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.18 AI in Drug Manufacturing Market in Rest of the Asia-Pacific, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.19 AI in Drug Manufacturing Market in Middle East and North Africa, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.20 AI in Drug Manufacturing Market in Saudi Arabia, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.21 AI in Drug Manufacturing Market in UAE, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.22 AI in Drug Manufacturing Market in Egypt, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.23 AI in Drug Manufacturing Market in Rest of the Middle East and North Africa, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.24 AI in Drug Manufacturing Market in Latin America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.25 AI in Drug Manufacturing Market in Brazil, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.26 AI in Drug Manufacturing Market in Argentina, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.27 AI in Drug Manufacturing Market in Rest of Latin America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Figure 24.28 Penetration Growth (P-G) Matrix: Geographical Regions

Figure 24.29 Market Movement Analysis: Geographical Regions

+ List of Tables

Table 7.1 AI in Drug Manufacturing: Information on Year of Establishment, Headquarter and Company Size

Table 7.2 AI in Drug Manufacturing: Information on Company Ownership and Type of Company

Table 7.3 AI in Drug Manufacturing: Information on Type of AI Solution, Type of Offering, Type of Technology

Table 7.4 AI in Drug Manufacturing: Information on Mode of Deployment, Application Area

Table 7.5 AI in Drug Manufacturing: Information on Utility in Drug Manufacturing

Table 13.1 AI in Drug Manufacturing: List of Partnerships and Collaborations, since 2021

Table 12.1 AI in Drug Manufacturing: List of Funding and Investments, since 2021

Table 26.1 AI in Drug Manufacturing Market in North America: Distribution by Type of Offering, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 26.2 AI in Drug Manufacturing Market in North America: Distribution by Type of AI Solution, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 26.3 AI in Drug Manufacturing Market in North America: Distribution by Mode of Deployment, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 26.4 AI in Drug Manufacturing Market in North America: Distribution by Type of Technology, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 26.5 AI in Drug Manufacturing Market in North America: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 26.6 AI in Drug Manufacturing Market in North America: Distribution by Utility in Drug Manufacturing, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 27.1 AI in Drug Manufacturing Market in Europe: Distribution by Type of Offering, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 27.2 AI in Drug Manufacturing Market in Europe: Distribution by Type of AI Solution, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 27.3 AI in Drug Manufacturing Market in Europe: Distribution by Mode of Deployment, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 27.4 AI in Drug Manufacturing Market in Europe: Distribution by Type of Technology, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 27.5 AI in Drug Manufacturing Market in Europe: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 27.6 AI in Drug Manufacturing Market in Europe: Distribution by Utility in Drug Manufacturing, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 28.1 AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Type of Offering, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 28.2 AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Type of AI Solution, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 28.3 AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Mode of Deployment, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 28.4 AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Type of Technology, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 28.5 AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 28.6 AI in Drug Manufacturing Market in Asia-Pacific: Distribution by Utility in Drug Manufacturing, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 29.1 AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Type of Offering, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 29.2 AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Type of AI Solution, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 29.3 AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Mode of Deployment, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 29.4 AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Type of Technology, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 29.5 AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 29.6 AI in Drug Manufacturing Market in Middle East and North Africa: Distribution by Utility in Drug Manufacturing, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 30.1 AI in Drug Manufacturing Market in Latin America: Distribution by Type of Offering, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 30.2 AI in Drug Manufacturing Market in Latin America: Distribution by Type of AI Solution, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 30.3 AI in Drug Manufacturing Market in Latin America: Distribution by Mode of Deployment, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 30.4 AI in Drug Manufacturing Market in Latin America: Distribution by Type of Technology, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 30.5 AI in Drug Manufacturing Market in Latin America: Distribution by Application Area, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

Table 30.6 AI in Drug Manufacturing Market in Latin America: Distribution by Utility in Drug Manufacturing, Historical Trends (Since 2021) and Forecasted Estimates (Till 2040) (USD Million)

**Detailed information on Tables 26.1-30.3 is available in the Excel Data Packs shared along with the report

Table 33.1 AI in Drug Manufacturing: Distribution by Year of Establishment

Table 33.2 AI in Drug Manufacturing: Distribution by Company Size

Table 33.3 AI in Drug Manufacturing: Distribution by Location of Headquarters (Region)

Table 33.4 AI in Drug Manufacturing: Distribution by Location of Headquarters (Country)

Table 33.5 AI in Drug Manufacturing: Distribution by Company Ownership

Table 33.6 AI in Drug Manufacturing: Distribution by Type of Company

Table 33.7 AI in Drug Manufacturing: Distribution by Type of AI Solution

Table 33.8 AI in Drug Manufacturing: Distribution by Type of Offering

Table 33.9 AI in Drug Manufacturing: Distribution by Type of Technology

Table 33.10 AI in Drug Manufacturing: Distribution by Mode of Deployment

Table 33.11 AI in Drug Manufacturing: Distribution by Application Area

Table 33.12 AI in Drug Manufacturing: Distribution by Utility in Drug Manufacturing

Table 33.13 C3.AI: Consolidated Financial Details, Since FY 2021 (USD Million)

Table 33.14 AMD: Consolidated Financial Details, Since FY 2021 (USD Million)

Table 33.15 IBM: Consolidated Financial Details, Since FY 2021 (USD Million)

Table 33.16 Kalypso: A Rockwell Automation Business: Consolidated Financial Details, Since FY 2021 (USD Million)

Table 33.17 SAS: Consolidated Financial Details, Since FY 2021 (USD Million)

Table 33.18 Körber Pharma: Consolidated Financial Details, Since FY 2021 (USD Million)

Table 33.19 Elisa Industriq: Consolidated Financial Details, Since FY 2021 (USD Million)

Table 33.20 Axiomtek: Consolidated Financial Details, Since FY 2021 (USD Million)

Table 33.21 Partnerships and Collaborations: Distribution by Year of Partnership

Table 33.22 Partnerships and Collaborations: Distribution by Type of Partnership

Table 33.23 Partnerships and Collaborations: Distribution by Year and Type of Partnership

Table 33.24 Partnerships and Collaborations: Distribution by Type of Partner

Table 33.25 Partnerships and Collaborations: Distribution by Geographical Activity

Table 33.26 Partnerships and Collaborations: Distribution by Local and International Deals

Table 33.27 Partnerships and Collaborations: Intracontinental and Intercontinental Deals

Table 33.28 Most Active Players: Distribution by Number of Partnerships

Table 33.29 Funding and Investments: Cumulative Year-wise Trend of Fundings and Investments

Table 33.30 Funding and Investments: Distribution of Funding Instances by Type of Funding

Table 33.31 Funding and Investments: Year-wise Distribution of Funding Instances by Type of Funding

Table 33.32 Funding and Investments: Distribution of Amount Invested by Type of Funding

Table 33.33 Funding and Investments: Distribution of Funding Instances by Country

Table 33.34 Most Active Players: Distribution by Funding Instances

Table 33.35 Most Active Players: Distribution by Amount Raised (USD Million)

Table 33.36 Leading Investors: Distribution by Number of Funding Instances

Table 33.37 Funding and Investments: Summary

Table 33.38 Global AI in Drug Manufacturing Market, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.39 AI in Drug Manufacturing Market: Distribution by Type of Offering

Table 33.40 AI in Drug Manufacturing Market for Hardware, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.41 AI in Drug Manufacturing Market for Software Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.42 AI in Drug Manufacturing Market for Services, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.43 AI in Drug Manufacturing Market: Distribution by Type of AI Solution

Table 33.44 AI in Drug Manufacturing Market for Off-the-Shelf AI Solutions, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.45 AI in Drug Manufacturing Market for Personalized AI Solutions, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.46 AI in Drug Manufacturing Market: Distribution by Mode of Deployment

Table 33.47 AI in Drug Manufacturing Market for Cloud-based AI Solutions, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.48 AI in Drug Manufacturing Market for On-premise AI Solutions, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.49 AI in Drug Manufacturing Market: Distribution by Type of Technology

Table 33.50 AI in Drug Manufacturing Market for Computer Vision, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.51 AI in Drug Manufacturing Market for Machine Learning, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.52 AI in Drug Manufacturing Market for Deep Learning, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.53 AI in Drug Manufacturing Market for Generative AI, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.54 AI in Drug Manufacturing Market for Other Technologies, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.55 AI in Drug Manufacturing Market: Distribution by Application Area

Table 33.56 AI in Drug Manufacturing Market for Quality Control, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.57 AI in Drug Manufacturing Market for Predictive Maintenance, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.58 AI in Drug Manufacturing Market for Process Development and Optimization, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.59 AI in Drug Manufacturing Market for Plant or Equipment Performance Monitoring, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.60 AI in Drug Manufacturing Market for Supply Chain Optimization, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.61 AI in Drug Manufacturing Market for Other Application Areas, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.62 AI in Drug Manufacturing Market: Distribution by Utility in Drug Manufacturing

Table 33.63 AI in Drug Manufacturing Market for Defect Detection, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.64 AI in Drug Manufacturing Market for Packaging and Label Inspection, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.65 AI in Drug Manufacturing Market for Package Counting, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.66 AI in Drug Manufacturing Market for Fill Level Inspection, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.67 AI in Drug Manufacturing Market for Other Utilities, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.68 AI in Drug Manufacturing Market: Distribution by Geographical Regions

Table 33.69 AI in Drug Manufacturing Market in North America, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.70 AI in Drug Manufacturing Market in the US, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.71 AI in Drug Manufacturing Market in Canada, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.72 AI in Drug Manufacturing Market in Europe, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.73 AI in Drug Manufacturing Market in Germany, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.74 AI in Drug Manufacturing Market in France, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.75 AI in Drug Manufacturing Market in Spain, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.76 AI in Drug Manufacturing Market in Italy, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.77 AI in Drug Manufacturing Market in the UK, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.78 AI in Drug Manufacturing Market in Rest of Europe, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.79 AI in Drug Manufacturing Market in Asia-Pacific, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.80 AI in Drug Manufacturing Market in Australia, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.81 AI in Drug Manufacturing Market in China, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.82 AI in Drug Manufacturing Market in Japan, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.83 AI in Drug Manufacturing Market in India, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.84 AI in Drug Manufacturing Market in South Korea, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.85 AI in Drug Manufacturing Market in Rest of the Asia-Pacific, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.86 AI in Drug Manufacturing Market in Middle East and North Africa, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.87 AI in Drug Manufacturing Market in Saudi Arabia, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.88 AI in Drug Manufacturing Market in UAE, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.89 AI in Drug Manufacturing Market in Egypt, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.90 AI in Drug Manufacturing Market in Rest of Middle East and North Africa, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.91 AI in Drug Manufacturing Market in Latin America, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.92 AI in Drug Manufacturing Market in Brazil, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.93 AI in Drug Manufacturing Market in Argentina, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

Table 33.94 AI in Drug Manufacturing Market in Rest of Latin America, Historical Trends (since 2021) and Forecasted Estimated (till 2040): Conservative, Base and Optimistic Scenario (USD Million)

+ List of Companies and Organizations

Please reach out to our team for more details.

AI in Drug Manufacturing Market

Global AI in Drug Manufacturing Market Size

AI in Drug Manufacturing Market: Report Attributes

Recent Developments in AI in Drug Manufacturing Market

AI in Drug Manufacturing Market Segmentation Insights

AI in Drug Manufacturing Market: Market Segmentation

Industry Experts on Artificial Intelligence in Drug Manufacturing

Market Share by Type of Offering: Software Segment to Dominate the Overall Market

Market Share by Mode of Deployment: Cloud-based Solutions Hold the Largest Share

Market Share by Type of AI Solution: Off-the-shelf AI Solutions to Dominate the Overall Market

Market Share by Type of Technology: Computer Vision Holds the Largest Share

Market Share by Application Area: Supply Chain Optimization to propel the market in the Coming Years

Market Share by Utility in Drug Manufacturing: Defect Defection Holds the Largest Share

Regional Analysis of AI in Drug Manufacturing Market: Asia-Pacific to Propel in the Coming Years

AI in Drug Manufacturing Market: Report Deliverables

AI in Drug Manufacturing Market Key Takeaways

Competitive Landscape of AI Drug Manufacturing Companies

What are the Use Cases of Artificial Intelligence in Pharmaceutical Manufacturing?

Market Size Analysis: What is the Opportunity for AI in Drug Manufacturing?

Regional Analysis: Which Region Holds the Largest Share of the AI in Drug Manufacturing Market?

North America is Leading the Market

Asia-Pacific: An Emerging Growth Spot

What are the Key Drivers of Artificial Intelligence in Drug Manufacturing Market?

Key Market Trends in AI in Drug Manufacturing Market

Rising Partnerships and Collaborations amongst the Solution Providers to Foster Progress and Innovation in Expanding their Capabilities

Investment Trends in AI for Drug Manufacturing 2026

AI in Drug Manufacturing Market Report Coverage

Glossary

From the Author’s Desk

Author’s View on AI in Drug Manufacturing Market

About Authors

Table of Contents

The Future of Autonomous Deliveries: Integrating Drones and Self-Driving Vehicles

Radiopharmaceutical Manufacturing: A Multi-Disciplinary Endeavour for Medical Imaging and Interventional Treatment

AI in Drug Manufacturing Market

Global AI in Drug Manufacturing Market Size

AI in Drug Manufacturing Market: Report Attributes

Recent Developments in AI in Drug Manufacturing Market

AI in Drug Manufacturing Market Segmentation Insights

AI in Drug Manufacturing Market: Market Segmentation

Industry Experts on Artificial Intelligence in Drug Manufacturing

AI in Drug Manufacturing Market Share Insights

Market Share by Type of Offering: Software Segment to Dominate the Overall Market

Market Share by Mode of Deployment: Cloud-based Solutions Hold the Largest Share

Market Share by Type of AI Solution: Off-the-shelf AI Solutions to Dominate the Overall Market

Market Share by Type of Technology: Computer Vision Holds the Largest Share

Market Share by Application Area: Supply Chain Optimization to propel the market in the Coming Years

Market Share by Utility in Drug Manufacturing: Defect Defection Holds the Largest Share

Regional Analysis of AI in Drug Manufacturing Market: Asia-Pacific to Propel in the Coming Years

AI in Drug Manufacturing Market: Report Deliverables

AI in Drug Manufacturing Market Key Takeaways

Competitive Landscape of AI Drug Manufacturing Companies

What are the Use Cases of Artificial Intelligence in Pharmaceutical Manufacturing?

Market Size Analysis: What is the Opportunity for AI in Drug Manufacturing?

Regional Analysis: Which Region Holds the Largest Share of the AI in Drug Manufacturing Market?

North America is Leading the Market

Asia-Pacific: An Emerging Growth Spot

What are the Key Drivers of Artificial Intelligence in Drug Manufacturing Market?

Key Market Trends in AI in Drug Manufacturing Market

Rising Partnerships and Collaborations amongst the Solution Providers to Foster Progress and Innovation in Expanding their Capabilities

Investment Trends in AI for Drug Manufacturing 2026

AI in Drug Manufacturing Market Report Coverage

Glossary

From the Author’s Desk

Author’s View on AI in Drug Manufacturing Market

About Authors

Table of Contents

The Future of Autonomous Deliveries: Integrating Drones and Self-Driving Vehicles

Radiopharmaceutical Manufacturing: A Multi-Disciplinary Endeavour for Medical Imaging and Interventional Treatment